CPL Inc - Corporate Profile

CPL Inc., located in Washington DC, was founded in 1999 and is a wholly-owned subsidiary of Cadila Pharmaceuticals, Ltd., located in Ahmedabad, India. CPL Inc. was created as the sales, marketing and regulatory arm of Cadila Pharmaceuticals in North America and Latin America. In conjunction with Cadila Pharmaceuticals, CPL Inc. is committed to supplying quality active pharmaceutical ingredients and a variety of other research services using some of the most advanced research methods and cutting edge manufacturing processes in southeast Asia.

Cadila Pharmaceuticals Ltd.

For over 57 years, Cadila Pharmaceuticals Ltd has produced pharmaceutical ingredients, with well over 4,500 research, production, quality assurance, R&D, and quality formulation scientists and support personnel. Cadila Pharmaceuticals Ltd. has one of the largest and most advanced pharmaceutical manufacturing and R&D facilities on the Asian Subcontinent. Additionally, Cadila has recently expanded and modernized its research and development facilities campus, and now encompasses well over 45,000 square feet, up to par with U.S., European and international standards. With a staff of over 150 scientists, Cadila has one of the finest chemical R&D teams ever assembled. In recent years, Cadila has been granted many patents, using some of the latest techniques in biochemistry and molecular biology.